Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Nuvasive Inc (NUVA) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 3,315,920
  • Shares Outstanding, K 50,350
  • Annual Sales, $ 811,110 K
  • Annual Income, $ 66,290 K
  • 36-Month Beta 0.97
  • Price/Sales 4.09
  • Price/Book 4.59

Price Performance

See More
Period Period Low Period High Performance
1-Month
59.05 +13.18%
on 11/10/16
67.06 -0.34%
on 12/07/16
+7.14 (+11.96%)
since 11/07/16
3-Month
56.70 +17.87%
on 11/02/16
69.50 -3.84%
on 10/10/16
-0.41 (-0.61%)
since 09/07/16
52-Week
36.81 +81.55%
on 02/12/16
69.50 -3.84%
on 10/10/16
+16.11 (+31.76%)
since 12/07/15

Most Recent Stories

More News
NuVasive to Showcase Integrated Global Alignment for the Cervical Spine at CSRS 2016

SAN DIEGO, CA--(Marketwired - December 01, 2016) - NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated...

NuVasive to Showcase Integrated Global Alignment for the Cervical Spine at CSRS 2016

SAN DIEGO, CA--(Marketwired - December 01, 2016) - NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated...

NuVasive: Q3 Results Lack Shine, Spine Market Holds Promise

On Nov 28, we issued an updated research report on San Diego, CA-based NuVasive, Inc. (NUVA).

NuVasive (NUVA) Earnings & Revenues Miss Estimates in Q3

NuVasive, Inc. (NUVA) reported third-quarter 2016 adjusted earnings per share (EPS) of40 cents, missed the Zacks Consensus Estimate by a penny.

NuVasive Secures Magnetic Resonance (MR) FDA Conditional Clearance for MAGEC System

New Clearance Expands Access of Innovative Treatment for Pediatric Patients Suffering from Early Onset Scoliosis

NuVasive Secures Magnetic Resonance (MR) FDA Conditional Clearance for MAGEC System

New Clearance Expands Access of Innovative Treatment for Pediatric Patients Suffering from Early Onset Scoliosis

NuVasive Falls 7.79% on Heavy Volume: Watch For Potential Rebound

NuVasive (NASDAQ:NUVA) traded in a range yesterday that spanned from a low of $59.02 to a high of $61.22. Yesterday, the shares fell 7.8%, which took the trading range below the 3-day low of $64.53 on...

SmarTrend Watching for Potential Rebound in Shares of NuVasive After 7.79% Loss

NuVasive (NASDAQ:NUVA) traded in a range yesterday that spanned from a low of $59.02 to a high of $61.22. Yesterday, the shares fell 7.8%, which took the trading range below the 3-day low of $64.53 on...

NuVasive First-to-Market With New Spine Innovations Featured at NASS 2016

NuVasive Expands Integrated Global Alignment Platform to Support All Spinal Procedures; Company Solves Critical OR Need with Technology that Helps OR Staff Reduce Levels of Exposure to Surgical Radiation...

NuVasive First-to-Market With New Spine Innovations Featured at NASS 2016

NuVasive Expands Integrated Global Alignment Platform to Support All Spinal Procedures; Company Solves Critical OR Need with Technology that Helps OR Staff Reduce Levels of Exposure to Surgical Radiation...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

NUVASIVE is a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. The Company's product portfolio is focused on applications in the over $4.2 billion U.S. spine fusion market. The Company's current principal product offering...

See More

Support & Resistance

2nd Resistance Point 67.98
1st Resistance Point 67.41
Last Price 66.83
1st Support Level 65.90
2nd Support Level 64.97

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.